Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
RGLS Regulus Therapeutics
- 3.490
- +0.730+26.45%
Trading Apr 28 11:31 ET
231.20MMarket Cap-4.26P/E (TTM)
3.500High2.758Low1.83MVolume2.780Open2.760Pre Close5.84MTurnover4.07%Turnover RatioLossP/E (Static)66.24MShares3.44052wk High3.03P/B156.62MFloat Cap0.83052wk Low--Dividend TTM44.87MShs Float3071.997Historical High--Div YieldTTM26.90%Amplitude0.760Historical Low3.195Avg Price1Lot Size
Regulus Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -55.68%-41.67M | -93.39%-11.85M | -50.53%-9.45M | -86.13%-11.64M | -7.74%-8.74M | -4.87%-26.77M | 2.05%-6.13M | 6.77%-6.28M | -1.51%-6.25M | -27.16%-8.11M |
| Net income from continuing operations | -54.34%-46.36M | -58.68%-12.79M | -79.73%-14.06M | -57.36%-11.04M | -18.63%-8.47M | -6.05%-30.04M | -18.63%-8.06M | -3.62%-7.82M | 3.38%-7.01M | -6.25%-7.14M |
| Depreciation and amortization | 52.86%347K | 14.47%87K | 60.71%90K | 89.36%89K | 68.75%81K | 86.07%227K | 130.30%76K | 75.00%56K | 51.61%47K | 84.62%48K |
| Other non cash items | -70.21%42K | --0 | --0 | -80.00%10K | 3.23%32K | 6.02%141K | -12.50%28K | 3.23%32K | 56.25%50K | -18.42%31K |
| Change In working capital | -832.30%-1.88M | -244.09%-1.22M | 401.68%2.69M | -758.16%-1.86M | -6.61%-1.5M | -53.27%257K | 297.18%846K | 25.76%537K | -55.66%282K | -93.94%-1.41M |
| -Change in receivables | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -87.50%1K | 50.00%-4K |
| -Change in prepaid assets | -525.25%-2.16M | -1,855.36%-2.19M | 852.48%1.52M | -1,370.39%-1.93M | -33.48%445K | 856.72%507K | 87.11%-112K | -7.45%-202K | -50.81%152K | -1.76%669K |
| -Change in payables and accrued expense | 2,144.00%1.68M | 7.64%634K | 49.29%1.26M | 268.47%1.57M | 0.39%-1.77M | -88.65%75K | 41.93%589K | 36.03%842K | -36.94%425K | -70.11%-1.78M |
| -Change in other current liabilities | -445.80%-1.3M | -6.87%366K | 36.14%-53K | -433.94%-1.46M | 45.62%-149K | -1,290.00%-238K | -42.63%393K | -692.86%-83K | 19.17%-274K | 19.41%-274K |
| -Change in other working capital | -26.44%-110K | -20.83%-29K | -30.43%-30K | -27.27%-28K | -27.78%-23K | -35.94%-87K | -33.33%-24K | -27.78%-23K | -37.50%-22K | -50.00%-18K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -55.68%-41.67M | -93.39%-11.85M | -50.53%-9.45M | -86.13%-11.64M | -7.74%-8.74M | -4.87%-26.77M | 2.05%-6.13M | 6.77%-6.28M | -1.51%-6.25M | -27.16%-8.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -348.31%-35.98M | 386.62%24M | 442.72%18.64M | -83K | -623.66%-78.54M | 195.84%14.49M | -52.88%4.93M | 57.70%-5.44M | 0 | 14,804.90%15M |
| Net PPE purchase and sale | 44.26%-340K | --0 | 94.82%-28K | ---83K | -22,800.00%-229K | -68.98%-610K | -7.94%-68K | -17,933.33%-541K | --0 | 99.02%-1K |
| Net investment purchase and sale | -336.03%-35.64M | 380.00%24M | 481.14%18.67M | --0 | -622.10%-78.32M | 202.32%15.1M | -52.52%5M | 61.90%-4.9M | --0 | --15M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -348.31%-35.98M | 386.62%24M | 442.72%18.64M | ---83K | -623.66%-78.54M | 195.84%14.49M | -52.88%4.93M | 57.70%-5.44M | --0 | 14,804.90%15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 682.13%92.42M | 0 | -80.49%56K | -105.63%-744K | 11,665.84%93.11M | 163.10%11.82M | -873K | -93.61%287K | 13.21M | -40,350.00%-805K |
| Net issuance payments of debt | 58.32%-1.38M | --0 | --0 | 33.29%-551K | 0.00%-826K | ---3.3M | ---826K | ---826K | ---826K | ---826K |
| Net common stock issuance | 520.31%93.79M | --0 | -94.97%56K | -101.38%-194K | 447,180.95%93.93M | 236.67%15.12M | ---47K | -75.21%1.11M | --14.03M | 950.00%21K |
| Proceeds from stock option exercised by employees | --3K | --0 | --0 | --1K | --2K | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 682.13%92.42M | --0 | -80.49%56K | -105.63%-744K | 11,665.84%93.11M | 163.10%11.82M | ---873K | -93.61%287K | --13.21M | -40,350.00%-805K |
| Net cash flow | ||||||||||
| Beginning cash position | -1.90%23.83M | 2.09%26.44M | -53.96%17.18M | -2.38%29.65M | -1.90%23.83M | -59.81%24.29M | 28.98%25.9M | 6.09%37.33M | -43.72%30.37M | -59.81%24.29M |
| Current changes in cash | 3,301.95%14.76M | 688.33%12.16M | 180.94%9.25M | -279.21%-12.46M | -4.29%5.82M | 98.72%-461K | -149.03%-2.07M | 24.33%-11.43M | 137.03%6.96M | 193.81%6.08M |
| End cash Position | 61.95%38.59M | 61.95%38.59M | 2.09%26.44M | -53.96%17.18M | -2.38%29.65M | -1.90%23.83M | -1.90%23.83M | 28.98%25.9M | 6.09%37.33M | -43.72%30.37M |
| Free cash flow | -53.44%-42.01M | -91.17%-11.85M | -39.00%-9.48M | -87.46%-11.72M | -10.55%-8.97M | -5.77%-27.38M | 1.90%-6.2M | -1.22%-6.82M | 1.57%-6.25M | -25.17%-8.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now